Pratik S Multani's Net Worth
$2.7 Million
Who is Pratik S Multani?
Pratik S Multani has an estimated net worth of $2.7 Million. This is based on reported shares across multiple companies, which include Erasca, Inc., CHIMERIX INC, FATE THERAPEUTICS INC, Ignyta, Inc., and Oric Pharmaceuticals, Inc..
SEC CIK
Pratik S Multani's CIK is 0001586894
Past Insider Trading and Trends
2022 was Pratik S Multani's most active year for acquiring shares with 8 total transactions. Pratik S Multani's most active month to acquire stocks was the month of December. 2022 was Pratik S Multani's most active year for disposing of shares, totalling 6 transactions. Pratik S Multani's most active month to dispose stocks was the month of November. 2021 saw Pratik S Multani paying a total of $99,200.00 for 131,200 shares, this is the most they've acquired in one year. In 2018 Pratik S Multani cashed out on 324,134 shares for a total of $2,001,618.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Erasca, Inc. (ERAS) Snapshot price: $2.86
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +3.72% | 6.2K |
$16.00 | $99,200.00 | 172.87K |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIMERIX INC (CMRX) Snapshot price: $0.8503
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.02K |
—
|
—
| 3.02K |
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ignyta, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -74.13K |
$27.00 | -$2,001,618.00 |
0
|
Feb 8
| |||
Form 4
| +6.31% | 4.4K |
—
|
—
| 74.13K |
Jan 5
| |||
Form 4
| +50.29% | 23.33K |
—
|
—
| 69.73K |
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +132.00% | 26.4K |
—
|
—
| 46.4K |
Jan 7
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oric Pharmaceuticals, Inc. (ORIC) Snapshot price: $9.65
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +58.21% | 8.76K |
$8.59 | -$45,350.72 | 23.81K |
Dec 15
| |||
Form 4/A
| -23.41% | -2.23K |
$3.07 | -$6,845.58 | 7.29K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +113.86% | 3.95K |
$3.25 | -$6,789.25 | 7.42K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||